BRAF and nevus: This interpretation is directly supported by the immunostaining of melanocytic nevi with an antibody (VE1) specific for BRAFV600E mutation, resulting in the detection of this genetic abnormality in all melanocytes comprising a BRAF-mutated nevus [32].